Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if GRDX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 6
19 filers reported a long position in GRDX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $826.8K | 176.3K | -4.1% |
| CITADEL ADVISORS LLC | $400.2K | 85.3K | New |
| Federation des caisses Desjardins du Quebec | $358.1K | 76.4K | +59.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $347.3K | 74.1K | +304.9% |
| GEODE CAPITAL MANAGEMENT, LLC | $280.9K | 59.9K | +80% |
| JANE STREET GROUP, LLC | $230.9K | 49.2K | +289% |
| VANGUARD FIDUCIARY TRUST CO | $158.5K | 33.8K | +106.8% |
| STATE STREET CORP | $110K | 23.4K | Unchanged |
| HRT FINANCIAL LP | $98K | 21K | New |
| Independent Advisor Alliance | $70.4K | 15K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.